Click here to view the Humana Medical Policy Updates Updates » September 2024 Humana Medical…
BCBS Massachusetts Medical Policy Updates – December 2018
December 2018 Medical Policy Updates:
- Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias
- Allogeneic Hematopoietic Cell transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms
- Alphabetical Index of Policies
- Assisted Reproductive Services Infertility Services
- Assisted Reproductive Technology Services Form for Policy Infertility Diagnosis and Treatment
- Asthma and Chronic Obstructive Pulmonary Disease Medication Management
- Autologous Hematopoietic Stem Cell Transplantation for Malignant
- Biomarkers for Diagnosis & Cancer Risk Assessment of Prostate Cancer
- Calcitonin Gene-Related Peptide
- Compound Medications Exclusion Drug List
- Compound Medications Inclusion Drug List
- Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid
- Diabetes Step Therapy
- Dificid fidaxomicin
- Directory of Documents, 411
- Drug Management and Prior Authorization
- Endovascular Stent Grafts for Disorders of the Thoracic Aorta
- Epidural Steroid Injections for Neck and Back Pain
- Expanded Molecular Panel Testing of Cancers to Identify Targeted Therapies
- Growth Hormone and Insulin-like Growth Factor
- Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
- Hematopoietic Cell Transplantation for Autoimmune Diseases
- Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia
- Hematopoietic Cell Transplantation for CNS Embryonal Tumors and Ependymoma
- Hematopoietic Cell Transplantation for Epithelial Ovarian Cancer
- Hematopoietic Cell Transplantation for Hodgkin Lymphoma
- Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in Adults
- Hematopoietic Cell Transplantation for Non-Hodgkin Lymphomas
- Hematopoietic Cell Transplantation for Plasma Cell Dyscracias, Including Multiple Myeloma and POEMS Syndrome
- Hematopoietic Cell Transplantation for Primary Amyloidosis
- Hematopoietic Cell Transplantation for Solid Tumors of Childhood
- Hematopoietic Cell Transplantation in the Treatment of Germ-Cell Tumors
- Hematopoietic Stem-Cell Transplantation for Waldenstrom Macroglobulinemia
- Hip Resurfacing
- Immune Modulating Drugs
- Immunomodulators for Skin Conditions
- Intraoperative Neurophysiologic Monitoring (Sensory-Evoked Potentials, Motor-Evoked Potentials, EEG Monitoring)
- Intravenous Anesthetics for the Treatment of Chronic Pain and Depression
- Intravenous Immunoglobulin
- Medical Policies
- Medical Policy Group Schedule
- Medical Policy Updates
- Medical Technology Assessment NonCovered Services
- Noncovered Drug List
- Optical Diagnostic Devices for Evaluating Skin Lesions Suspected of Malignancy
- Plastic Surgery
- Preauthorization Request Form for Diagnosis and Treatment of Sacroiliac Joint Pain for MP 320
- Preauthorization Request Form for Gene Therapy for Inherited Retinal Dystrophy
- Prior Authorization Request Form for Artificial Intervertebral Disc Cervical Spine MP 585
- Prior Authorization Request Form for CAR T-Cell Therapy Services for B-cell Acute Lymphoblastic Leukemia (tisagenlecleucel) MP 455
- Prior Authorization Request Form for CAR T-Cell Therapy Services for Treatment of Diffuse Large B-cell Lymphoma
- Prior Authorization Request Form for Myoelectric Prosthetic and Components for the Upper Limb MP 227
- Prior Authorization Request Form for Surgical and Transesophageal Endoscopic Procedures to Treat Gastroesophageal Reflux Disease
- Prior Authorization Request Form for Therapeutic Radiopharmaceuticals in Oncology Lutetium 177
- Prostatic Urethral Lift
- Proton Pump Inhibitors
- Quality Care Dosing Guidelines Drug List
- Therapeutic Radiopharmaceuticals in Oncology
- Wireless Capsule Endoscopy as a Diagnostic Technique in Disorders of the Small Bowel, Esophagus, and Colon
Click here to view the Blue Cross Blue Shield Massachusetts Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.